Reversal Reaction in A Borderline Lepromatous Leprosy Patient After COVID-19 Vaccine: Prevention or Risks?. J Pak Assoc Dermatol 2022, 32 (3), 609-612. https://doi.org/10.66344/jpad.32.3.2022.1953.